DRonabinol Treatment of OSA

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

Dronabinol

Open label Dronabinol treatment for two weeks.

Trial Locations (1)

RECRUITING

Jesse Brown VA Medical Center, Chicago, IL, Chicago

All Listed Sponsors

collaborator

University of Illinois at Chicago

OTHER

lead

VA Office of Research and Development

FED

NCT06477952 - DRonabinol Treatment of OSA | Biotech Hunter | Biotech Hunter